Amgen Announces Rhode Island Will Be Location Of First US Next-Generation Biomanufacturing Plant

Revolutionary, Innovative Plant Offers Greater Flexibility, Speed and Efficiency THOUSAND OAKS, Calif., April 10, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its campus in West Greenwich, R.I. The new plant, the first of its kind in the United States (U.S.), will employ Amgen's proven next-generation biomanufacturing capabilities and manufacture products for the U.S. and global markets. A next-generation biomanufacturing plant incorporates multiple innovative technologies into a single facility, and therefore is built in half the construction time with approximately one half of the operating ...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news